A tale of two tumours and a plea for progress

Lancet Oncol. 2012 Feb;13(2):124-5. doi: 10.1016/S1470-2045(12)70005-0.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Clinical Trials, Phase III as Topic
  • Humans
  • Indoles / therapeutic use*
  • Ipilimumab
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / pathology
  • Melanoma / drug therapy*
  • Melanoma / pathology
  • Middle Aged
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Sulfonamides / therapeutic use*
  • Vemurafenib
  • Young Adult

Substances

  • Antibodies, Monoclonal
  • Indoles
  • Ipilimumab
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf